Liver: a target of late diabetic complications

S Herzig1

  • 1Joint Research Division Molecular Metabolic Control, German Cancer Research Center, University of Heidelberg, University Hospital Heidelberg, Germany. s.herzig@dkfz.de

Insights

Diabetic liver dysfunction is an understudied long-term complication. Recent research highlights its impact on disease outcomes and mortality, focusing on transcriptional regulators.

Area of Science:

  • Metabolic dysfunction
  • Diabetic complications
  • Liver function

Background:

  • Metabolic liver dysfunction is linked to obesity-related type 2 diabetes and Metabolic Syndrome.
  • Long-term diabetic complications typically focus on vascular issues (nephropathy, retinopathy, atherosclerosis).
  • Emerging research identifies liver dysfunction as a significant, yet underexplored, late diabetic complication.

Purpose of the Study:

  • To explore the role of liver dysfunction as a long-term complication of diabetes.
  • To discuss recent advancements in understanding hepatic dysfunction in established diabetes.
  • To focus on transcriptional regulators involved in diabetic liver dysfunction.

Main Methods:

  • Literature review of recent studies on diabetic liver complications.
  • Analysis of transcriptional regulators impacting hepatic function in diabetes.
  • Discussion of the link between hyperglycemic conditions and liver disturbances.

Main Results:

  • Liver dysfunction is increasingly recognized as a critical factor in long-term diabetic complications.
  • Transcriptional regulators play a key role in mediating hepatic dysfunction in diabetes.
  • Disturbances in liver function significantly affect patient outcomes and mortality rates.

Conclusions:

  • Diabetic liver dysfunction is a novel and important area of diabetic late complications.
  • Understanding the transcriptional regulation of hepatic dysfunction is crucial for managing diabetes.
  • Further research into liver-specific complications is needed to improve diabetic patient care.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...